The rapid integration of artificial intelligence (AI) into healthcare settings across the United States presents significant opportunities and profound challenges. Legislative approaches to regulating AI in healthcare are diverse, reflecting the complex needs of balancing patient safety with
ICU Medical, a prominent medical device company based in California, is currently navigating significant regulatory challenges related to their infusion pumps. These challenges have emerged following an FDA warning, which highlighted the company's failure to adhere to essential regulatory
The field of acute coronary syndrome (ACS) care has witnessed significant advancements, driven by an evolving understanding of patient management practices and continuous clinical research efforts. These innovations encompass various aspects of treatment, from rethinking established protocols like
The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among
Roche's Columvi, a bispecific antibody known as glofitamab, has been approved by the European Commission (EC) for use in combination with gemcitabine and oxaliplatin (GemOx) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults who are not candidates for autologous
The imposition of tariffs on pharmaceuticals presents a looming threat to medication costs and availability, especially considering Georgia's significant dependence on these imports. Initially exempt from recent global White House tariffs, this reprieve is under reconsideration, potentially
